Ramesa Shafi | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Published on by Academic Excellence

Best Researcher Award

Ramesa Shafi
King Saud University, Saudi Arabia

Ramesa Shafi
Affiliation King Saud University
Country Saudi Arabia
Scopus ID 57442927600
Documents 105
Citations 1,901
h-index 25
Subject Area Biochemistry, Genetics and Molecular Biology
Event International Academic Excellence Awards
ORCID 0000-0003-2149-6239

Ramesa Shafi is a researcher affiliated with King Saud University whose scholarly profile is situated within biochemistry, genetics and molecular biology. The available research record indicates activity spanning molecular responses, microbiota, probiotics, nanomaterials, cancer biology and physiological stress. The profile reports 105 documents, 1,901 citations and an h-index of 25, providing quantitative indicators of sustained scholarly output and citation impact.

Abstract

This academic recognition profile presents the research record of Ramesa Shafi in biochemistry, genetics and molecular biology. Recent publications address biological activities of plant-derived silver nanoparticles, probiotic and bee-pollen interventions, microbiota in lupus nephritis, adrenomedullin expression in breast cancer and biochemical responses to sodium halide stress. These studies collectively illustrate an interdisciplinary approach to molecular and physiological research.[1]

Keywords

Biochemistry; Genetics; Molecular Biology; Microbiota; Probiotics; Nanoparticles; Cancer Biology; Physiological Stress; Research Excellence.

Introduction

Research in biochemistry and molecular biology increasingly connects cellular mechanisms with environmental, nutritional and disease-related responses. Shafi’s reported publications reflect this multidisciplinary direction, with studies examining molecular pathways and biological responses across experimental and clinical contexts.[2]

Research Profile

The research profile is characterized by work at the intersection of biochemical processes, molecular regulation and biological responses. The reported Scopus metrics—105 documents, 1,901 citations and an h-index of 25—provide measurable indicators of publication activity and scholarly influence.[1]

Research Contributions

  • Investigation of biological activities associated with Ocimum basilicum flower-derived silver nanoparticles.[2]
  • Evaluation of probiotic and bee-pollen supplementation in intestinal tight-junction responses.[3]
  • Analysis of microbiota as a potential therapeutic target in lupus nephritis.[4]
  • Study of adrenomedullin and receptor expression in breast cancer among Saudi patients.[5]

Publications

  • Biological Activities and Host-Response Insights of Ocimum basilicum Flower-Derived Silver Nanoparticles. Inorganics, 2026.
  • Multi-Strain Probiotic and Bee Pollen Supplementation Attenuates CCl4-Induced Altered Intestinal Tight Junctions in Rodents. Current Issues in Molecular Biology, 2026.
  • The Dual Role of Microbiota as a Therapeutic Target in Lupus Nephritis. Turkish Journal of Nephrology, 2025.
  • Expression Patterns of Adrenomedullin and its Receptors in Breast Cancer Among Saudi Patients. International Journal of Pharmacology, 2025.
  • Biochemical and Physiological Responses to Sodium Halide Stress in Mung Beans Sprouts. Fluoride – Quarterly Reports, 2025.

Research Impact

The reported citation count and h-index indicate that the research output has received measurable scholarly attention. The diversity of publication topics also demonstrates relevance across molecular biology, nutrition-related interventions, disease mechanisms and nanobiotechnology.[1]

Award Suitability

Based on the supplied publication record and bibliometric indicators, Shafi presents a profile relevant to consideration for the Best Researcher Award. The combination of sustained publication activity, citation impact and interdisciplinary research themes provides a reasonable scholarly basis for evaluation under research-output and impact criteria.

Conclusion

Ramesa Shafi’s research profile reflects continued engagement with biochemistry, genetics and molecular biology. Recent work covers nanomaterials, microbiota, probiotics, cancer biology and biochemical stress responses, while the reported bibliometric indicators provide additional evidence of an established research record.

References

  1. Elsevier. (n.d.). Scopus author details: Ramesa Shafi, Author ID 57442927600. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57442927600
  2. MDPI. (2026). Biological Activities and Host-Response Insights of Ocimum basilicum Flower-Derived Silver Nanoparticles. Inorganics.
    https://doi.org/10.3390/inorganics14080216
  3. MDPI. (2026). Multi-Strain Probiotic and Bee Pollen Supplementation Attenuates CCl4-Induced Altered Intestinal Tight Junctions in Rodents. Current Issues in Molecular Biology.
    https://doi.org/10.3390/cimb48030310
  4. Turkish Journal of Nephrology. (2025). The Dual Role of Microbiota as a Therapeutic Target in Lupus Nephritis.
    https://doi.org/10.5152/turkjnephrol.2025.25981
  5. International Journal of Pharmacology. (2025). Expression Patterns of Adrenomedullin and its Receptors in Breast Cancer Among Saudi Patients.
    https://doi.org/10.3923/ijp.2025.200.208
  6. Publons / Web of Science. (2025). Biochemical and Physiological Responses to Sodium Halide Stress in Mung Beans Sprouts.
    https://publons.com/wos-op/publon/76884309/

Nobendu Mukerjee | Biochemistry | Young Scientist Award

Published on by Academic Excellence

Mr. Nobendu Mukerjee | Biochemistry | Young Scientist Award

University of Houston | India

Nobendu Mukerjee is an emerging researcher in cancer biology and microbiology, dedicated to bridging bioinformatics and wet-lab research to uncover molecular mechanisms driving cancer progression and to develop novel therapeutic strategies. He holds an M.Sc. in Microbiology from West Bengal State University with an outstanding CGPA of 9.78, following a B.Sc. (Hons.) in Microbiology from Ramakrishna Mission Vivekananda Centenary College. His research primarily focuses on exosome-mediated PROTAC delivery systems and phytochemical-based cancer therapies. During his academic journey, Nobendu has gained significant research experience at reputed institutions such as the A*STAR Institute of Molecular and Cell Biology (Singapore), Tripura University, St. Xavier’s College Kolkata, Sambalpur University, and Banaras Hindu University. His work explores therapeutic nanodelivery, protein–ligand interactions, and computational drug design aimed at targeted cancer treatments. As a first author in multiple high-impact publications across journals like Chemical Engineering Journal, Drug Discovery Today, ACS Applied Nano Materials, and Journal of Medical Virology, he has made valuable contributions to the fields of cancer therapeutics, exosome biology, and molecular medicine. His excellence has been recognized through prestigious fellowships, including the Singapore International Pre-Graduate Award (SIPGA) and the SPARK Fellowship from IIT Roorkee & BHU. Currently serving as a Lecturer at Saveetha Medical College and Hospital, Chennai, Nobendu remains committed to advancing precision medicine through integrative bioengineering approaches. His vision is to translate laboratory innovations into clinically transformative cancer therapies that can reshape the future of oncology.

Profiles: Scopus | Orcid

Featured Publications

  • Mukerjee, N., Maitra, S., Kaur, M., Rekha, M. M., Soothwal, P., Arora, I., Thorat, N. D., Sharma, P. K., & Kaushik, A. (2025). Click chemistry-based modified exosomes: Towards enhancing precision in cancer theranostics. Chemical Engineering Journal, 475, 160915.

  • Mohite, P., Puri, A., Munde, S., Yadav, V., Mukerjee, N., Patil, R., Mahindrakar, N., Siva Prasad, G. V., Verma, R., & Sinha, A. (2025). Exosome-mediated intercellular communication and PROTACs delivery: A dual approach for precision therapy in colon cancer. Journal of Drug Delivery Science and Technology, 87, 106596.

  • Mukerjee, N., Maitra, S., Ghosh, A., Alexiou, A., & Thorat, N. D. (2024). Exosome-mediated PROTAC delivery for treatment of RNA viral infections and zoonosis. Drug Discovery Today, 29(5), 104044.

  • Dhar, R., Mukerjee, N., Mukherjee, D., Devi, A., Jha, S. K., & Gorai, S. (2024). Plant-derived exosomes: A new dimension in cancer therapy. Phytotherapy Research, 38(7), 7828.

  • Mukerjee, N., Maitra, S., & Sharma, R. (2024). Proteolysis-targeting chimeras in antiviral therapy: Leveraging influenza virus and exosome-mediated delivery for targeted protein degradation and therapeutic advancements. Drug Development Research, 85(4), 22145.